Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 179

The DOI matches its Crossref record.

Current Therapy for Crigler–Najjar Syndrome Type 1: Report of A World Registry

van der Veere, C N, Sinaasappel, M, McDonagh, A F, Rosenthal, P, Labrune, P, Odiévre, M, Fevery, J, Otte, J, McClean, P, Bürk, G, Masakowski, V, Sperl, W, Mowat, A P, Vergani, G M, Heller, K, Wilson, J P, Shepherd, R, Jansen, P L·1996·Hepatology

Abstract

This study represents a multicenter survey on the management of patients with Crigler–Najjar syndrome (CNS) type 1. The aim of the survey was to find guiding principles for physicians in the care of these patients. Fifty–seven patients were included. At the time of inclusion, 21 patients had received a liver transplant (37%). The average age at transplantation was 9.1 ± 6.9 years (range, 1-23 years); the age of the patients who had not been transplanted at the time of inclusion was 6.9 ± 6.0 years (range, 0-23 years). Brain damage had developed in 15 patients (26%). Five patients died, and 10 are alive with some degree of mental or physical handicap. In 2 patients, ages 22 and 23 years, early signs of bilirubin encephalopathy could be reversed, in 1 by prompt medical intervention followed by liver transplantation and in the other by prompt liver transplantation. Seven patients underwent transplantation with some degree of brain damage at the time of the surgery; 1 of these died after retransplantation, 2 improved neurologically, and 4 remained neurologically impaired. The age of 8 patients with and 13 without brain damage at or before transplantation was 14.3 ± 5.9 and 5.9 ± 5.4 years ( P < .01), respectively. Therapy of CNS type 1 consists of phototherapy (12 h/d), followed by liver transplantation. Phototherapy, although initially very effective, is socially inconvenient and becomes less efficient in the older age group, thus also decreasing compliance. Currently, liver transplantation is the only effective therapy. This survey shows that, in a significant number of patients, liver transplantation is performed after some form of brain damage has already occurred. From this, one must conclude that liver transplantation should be performed at a young age, particularly in situations in which reliable administration of phototherapy cannot be guaranteed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.510240205

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 179

Metadata

Authors
van der Veere, C. N., Sinaasappel, M., McDonagh, A. F., Rosenthal, P., Labrune, P., Odiévre, M., Fevery, J., Otte, J., McClean, P., Bürk, G., Masakowski, V, Sperl, W., Mowat, A. P., Vergani, G. M., Heller, K., Wilson, J. P., Shepherd, R., & Jansen, P. L.
Venue
Hepatology
Published
1996-08
Volume
24
Issue
2
Pages
311-315
ISSN
0270-9139 (ISSN-L)
OpenAlex
W2014031811
Cited by
179
References
0
FWCI
4.97
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Current Therapy for Crigler–Najjar Syndrome Type 1: Report of A World Registry. https://app.cochat.ai/papers/10.1002/hep.510240205
The paper
van der Veere, C. N., Sinaasappel, M., McDonagh, A. F., Rosenthal, P., Labrune, P., Odiévre, M., Fevery, J., Otte, J., McClean, P., Bürk, G., Masakowski, V, Sperl, W., Mowat, A. P., Vergani, G. M., Heller, K., Wilson, J. P., Shepherd, R., & Jansen, P. L. (1996). Current Therapy for Crigler–Najjar Syndrome Type 1: Report of A World Registry. Hepatology. https://doi.org/10.1002/hep.510240205

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.